Added to YB: 2024-11-25
Pitch date: 2024-11-22
IPA [bullish]
ImmunoPrecise Antibodies Ltd.
+439.3%
current return
Author Info
No bio for this author
Company Info
ImmunoPrecise Antibodies Ltd. operates as a techbio company. It leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies; and support the discovery and development of therapeutic antibodies.
Market Cap
$110.2M
Pitch Price
$0.37
Price Target
4.50 (+126%)
Dividend
N/A
Sector
Life Sciences Tools and Services
Category
value
$IPA Quick Pitch
IPA: Busted biotech uplist at 0.4x PB, 1.1x NTM EV/Sales. World-class CRO (19/20 global pharma clients), drug discovery platform (MTA w/ BNTX subsidiary), AI platform (patented tech, SaaS model). CAD$25m rev (+19% YoY). Catalysts: mgmt change, asset sale, BioStrand commercialization, partnerships. CRO worth $100m+. Downside limited.
Read full article (7 min)